Emtora Biosciences
is a clinical-stage biopharmaceutical company that develops and commercializes novel therapies for the treatment of cancer and genetic diseases... Read moreEmtora Biosciences
is a clinical-stage biopharmaceutical company that develops and commercializes novel therapies for the treatment of cancer and genetic diseases... Read more
News
Apr 30, 2024
GlobeNewswire
Press Release: Emtora Biosciences : Biodexa's Licensor Emtora to Announce Phase 2 Clinical Trial Results of eRapa in Familial Adenomatous Polyposis to be Presented at Prestigious 2024 Digestive Disease Week Annual Meeting
Aug 20, 2022
FinSMEs
Emtora Biosciences: Emtora Biosciences Receives $16.9M Grant from the Cancer Prevention & Research Institute of Texas
Aug 19, 2022
BioSpace
Emtora Biosciences: Emtora Awarded $16.9M Grant from the Cancer Prevention & Research Institute of Texas
Aug 26, 2021
The Business Journals: San Antonio
Emtora Biosciences: SA biotech advancing drug development with mystery CEO
Feb 05, 2020
BioPortfolio
Emtora Biosciences: Emtora Biosciences Presents Phase Ib Data in Low Grade Prostate Cancer Patients at the 2020 ASCOSITC Clinical ImmunoOncology Symposium
Oct 22, 2019
The Business Journals: San Antonio
Emtora Biosciences: SA drug development company seeking new CEO
Aug 27, 2019
FinSMEs
Emtora Biosciences: Emtora Biosciences Receives $3M CPRIT Grant
Apr 30, 2019
Xconomy
Emtora Biosciences: Emtora Biosciences Turns Sights on Rare Genetic Disease, New Funding
Mar 13, 2019
The Business Journals
Emtora Biosciences: Emtora Biosciences CEO talks new name, focus and finish line
